Total Payments
$450,574
2024 Payments
$50,125
Companies
28
Transactions
705
Medicare Patients
7,064
Medicare Billing
$418,724
Payment Breakdown by Category
Other$392,361 (87.1%)
Travel$31,671 (7.0%)
Food & Beverage$19,346 (4.3%)
Consulting$7,057 (1.6%)
Education$139.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $391,161 | 140 | 86.8% |
| Travel and Lodging | $31,671 | 127 | 7.0% |
| Food and Beverage | $19,346 | 429 | 4.3% |
| Consulting Fee | $7,057 | 4 | 1.6% |
| Honoraria | $1,200 | 1 | 0.3% |
| Education | $139.00 | 4 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $385,217 | 393 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $40,481 | 86 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $13,520 | 58 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $4,037 | 5 | $0 (2023) |
| Medtronic Vascular, Inc. | $1,964 | 24 | $0 (2018) |
| Chiesi USA, Inc. | $1,215 | 2 | $0 (2024) |
| PFIZER INC. | $644.57 | 25 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $520.49 | 21 | $0 (2024) |
| Amgen Inc. | $464.25 | 17 | $0 (2024) |
| Boston Scientific Corporation | $357.00 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,125 | 128 | Janssen Pharmaceuticals, Inc ($32,778) |
| 2023 | $36,635 | 100 | Janssen Pharmaceuticals, Inc ($22,536) |
| 2022 | $126,608 | 141 | Janssen Pharmaceuticals, Inc ($113,268) |
| 2021 | $75,877 | 96 | Janssen Pharmaceuticals, Inc ($59,660) |
| 2020 | $19,017 | 22 | Janssen Pharmaceuticals, Inc ($18,865) |
| 2019 | $60,863 | 68 | Janssen Pharmaceuticals, Inc ($60,368) |
| 2018 | $36,766 | 62 | Janssen Pharmaceuticals, Inc ($35,126) |
| 2017 | $44,683 | 88 | Janssen Pharmaceuticals, Inc ($42,616) |
All Payment Transactions
705 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $66.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/01/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $29.56 | General |
| Category: Coronary | ||||||
| 10/28/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $26.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/09/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $21.71 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $13.53 | General |
| 10/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,120.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/28/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $18.46 | General |
| Category: Cardiovascular | ||||||
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Obesity | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $1,342.58 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/25/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $127.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $129.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/24/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $5.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/20/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.24 | General |
| Category: Cardiovascular | ||||||
| 09/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | Cash or cash equivalent | $100.50 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.32 | General |
| 09/13/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,605.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $62.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Travel and Lodging | In-kind items and services | $175.56 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/10/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $87.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,510 | 1,870 | $706,419 | $100,113 |
| 2022 | 31 | 1,966 | 2,383 | $852,910 | $115,719 |
| 2021 | 30 | 1,696 | 1,972 | $731,649 | $104,024 |
| 2020 | 28 | 1,892 | 2,198 | $686,055 | $98,868 |
Total Patients
7,064
Total Services
8,423
Medicare Billing
$418,724
Procedure Codes
125
All Medicare Procedures & Services
125 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 168 | 254 | $99,275 | $20,431 | 20.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 31 | 33 | $99,891 | $10,834 | 10.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 77 | $41,027 | $9,652 | 23.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 194 | 196 | $99,140 | $9,303 | 9.4% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 51 | 51 | $86,934 | $6,672 | 7.7% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2023 | 32 | 61 | $8,467 | $5,876 | 69.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 65 | $25,320 | $5,866 | 23.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 45 | 46 | $23,112 | $4,480 | 19.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 39 | 68 | $17,810 | $4,078 | 22.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $21,830 | $4,072 | 18.7% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 19 | 76 | $11,332 | $3,319 | 29.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 60 | 60 | $29,640 | $2,964 | 10.0% |
| Q9956 | Injection, octafluoropropane microspheres, per ml | Office | 2023 | 26 | 78 | $10,803 | $2,276 | 21.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 206 | 217 | $29,921 | $1,843 | 6.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 160 | 207 | $14,109 | $1,215 | 8.6% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 23 | 23 | $14,112 | $1,065 | 7.5% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 13 | $12,759 | $1,061 | 8.3% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 11 | 11 | $11,511 | $895.73 | 7.8% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 57 | 57 | $10,032 | $799.19 | 8.0% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 12 | 12 | $8,286 | $695.86 | 8.4% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 57 | 57 | $6,498 | $523.92 | 8.1% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 23 | 23 | $4,715 | $438.38 | 9.3% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Office | 2023 | 26 | 26 | $5,538 | $368.42 | 6.7% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2023 | 12 | 12 | $1,633 | $348.48 | 21.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 18 | 18 | $3,510 | $323.64 | 9.2% |
About Dr. Subhashish Agarwal, MD
Dr. Subhashish Agarwal, MD is a Emergency Medicine healthcare provider based in Brookfield, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134173875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Subhashish Agarwal, MD has received a total of $450,574 in payments from pharmaceutical and medical device companies, with $50,125 received in 2024. These payments were reported across 705 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($391,161).
As a Medicare-enrolled provider, Agarwal has provided services to 7,064 Medicare beneficiaries, totaling 8,423 services with total Medicare billing of $418,724. Data is available for 4 years (2020–2023), covering 125 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Cardiovascular Disease
- Location Brookfield, WI
- Active Since 05/19/2006
- Last Updated 02/14/2025
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1134173875
Products in Payments
- XARELTO (Drug) $385,203
- FARXIGA (Drug) $39,525
- LEQVIO (Drug) $12,975
- JUXTAPID (Drug) $1,200
- SelectSecure (Device) $806.33
- Performa (Device) $647.91
- BRILINTA (Drug) $583.50
- ENTRESTO (Drug) $545.30
- ELIQUIS (Drug) $417.12
- Repatha (Biological) $364.50
- CAMZYOS (Drug) $351.24
- VYNDAQEL (Drug) $318.22
- JARDIANCE (Drug) $293.99
- LifeVest (Device) $259.25
- AMVUTTRA (Drug) $174.80
- Amplia MRI (Device) $156.40
- TOUJEO (Drug) $119.92
- Kerendia (Drug) $109.37
- SHINGRIX (Biological) $104.00
- Corlanor (Drug) $99.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Brookfield
Mark Bruce, D. O, D. O
Emergency Medicine — Payments: $8,500
Emergency Medicine $8,500
Dr. Randall Ruvalcaba, Md, MD
Emergency Medicine — Payments: $539.30
Emergency Medicine $539.30
Gary Swart, M.d, M.D
Emergency Medicine — Payments: $348.50
Emergency Medicine $348.50
Michael Alper, Md, MD
Emergency Medicine — Payments: $236.42
Emergency Medicine $236.42
Dr. Jonathan Robinson, M.d, M.D
Emergency Medicine — Payments: $192.25
Emergency Medicine $192.25
Dr. Jerry Wait, Do, DO
Emergency Medicine — Payments: $55.66
Emergency Medicine $55.66